| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | OSI-930 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | Roscovitine | GDSC1000 | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.067 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | momelotinib | CTRPv2 | pan-cancer | AAC | 0.032 | 0.4 |